John Boletis
Overview
Explore the profile of John Boletis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
1105
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Furian L, Heemann U, Bengtsson M, Bestard O, Binet I, Bohmig G, et al.
Transpl Int
. 2025 Jan;
37:13886.
PMID: 39867871
Highly sensitized (HS) patients in need of kidney transplantation (KTx) typically spend a longer time waiting for compatible kidneys, are unlikely to receive an organ offer, and are at increased...
2.
Tsiakas S, Angelousi A, Benetou V, Orfanos P, Xagas E, Boletis J, et al.
J Clin Med
. 2024 Nov;
13(22).
PMID: 39597857
Glucocorticoids are commonly used for maintenance immunosuppressive therapy in kidney transplant recipients (KTRs). We aimed to investigate the prevalence of hypothalamic-pituitary-adrenal (HPA) axis suppression and its association with metabolic disorders...
3.
Panagiotopoulos A, Kapsia E, El Michelakis I, Boletis J, Marinaki S, Sfikakis P, et al.
Rheumatology (Oxford)
. 2024 Jul;
PMID: 39037915
Objectives: The optimal duration of immunosuppressive (IS) treatment for lupus nephritis (LN) remains uncertain. We assessed the prevalence and predictors of IS tapering and discontinuation (D/C) in LN patients. Methods:...
4.
Fanouriakis A, Kostopoulou M, Andersen J, Aringer M, Arnaud L, Bae S, et al.
Ann Rheum Dis
. 2023 Oct;
83(1):15-29.
PMID: 37827694
Objectives: To update the EULAR recommendations for the management of systemic lupus erythematosus (SLE) based on emerging new evidence. Methods: An international Task Force formed the questions for the systematic...
5.
Marinaki S, Vittoraki A, Tsiakas S, Kofotolios I, Darema M, Ioannou S, et al.
J Clin Med
. 2023 Jul;
12(13).
PMID: 37445510
Complement activation by HLA antibodies is a key component of immune-mediated graft injury. We examined the clinical outcomes of kidney transplant recipients with complement-fixing de novo donor-specific antibodies (dnDSA) who...
6.
Panagiotopoulos A, Kapsia E, Michelakis I, Boletis J, Marinaki S, Sfikakis P, et al.
RMD Open
. 2023 Jun;
9(2).
PMID: 37308249
Objective: A preliminary definition of disease modification (DM) in lupus nephritis (LN) was recently developed focusing on long-term remission and damage prevention, with minimal treatment-associated toxicity. We aimed to further...
7.
Sarafidis P, Agarwal R, Pitt B, Wanner C, Filippatos G, Boletis J, et al.
Clin J Am Soc Nephrol
. 2023 Mar;
18(5):602-612.
PMID: 36927680
Background: Patients with stage 4 CKD and type 2 diabetes have limited treatment options to reduce their persistent cardiovascular and kidney risk. In Finerenone in Chronic Kidney Disease and Type...
8.
Kapsia E, Marinaki S, Michelakis I, Liapis G, Sfikakis P, Boletis J, et al.
J Clin Med
. 2022 Sep;
11(17).
PMID: 36078950
To define predictors of response, time to response, flares, and long-term renal outcome in an inception cohort of proliferative lupus nephritis (PLN). We included 100 patients (80% female; mean age...
9.
Kapsia E, Marinaki S, Michelakis I, Liapis G, Sfikakis P, Tektonidou M, et al.
Front Med (Lausanne)
. 2022 May;
9:809533.
PMID: 35492303
Introduction: Pure membranous lupus nephritis (MLN) accounts for 10-20% of total cases of lupus nephritis and is generally associated with a better patient and renal survival compared to proliferative classes....
10.
Marinaki S, Tsiakas S, Skalioti C, Kapsia E, Lionaki S, Vallianou K, et al.
Front Med (Lausanne)
. 2022 Mar;
9:801144.
PMID: 35237623
Aim: Women with glomerular diseases are often of childbearing age. Besides lupus nephritis, data regarding pregnancy in patients with glomerular diseases are limited, posing a challenging task to attending nephrologists....